Report Detail
Women's Health - Medical Devices Pipeline Assessment, 2019
- RnM3864391 |
- 10 January, 2020 |
- Global |
- 603 Pages |
- GlobalData |
- Medical Devices & Consumables
Women's Health - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Women’s Health - Medical Devices Pipeline Assessment, 2019" provides an overview of Women’s Health currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Women’s Health pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Women’s Health under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Women’s Health and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Women’s Health under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 17
- 1.2 List of Figures 28
2 Introduction 29
- 2.1 Women's Health Overview 29
3 Products under Development 30
- 3.1 Women's Health - Pipeline Products by Stage of Development 30
- 3.2 Women's Health - Pipeline Products by Territory 31
- 3.3 Women's Health - Pipeline Products by Regulatory Path 33
- 3.4 Women's Health - Pipeline Products by Estimated Approval Date 34
- 3.5 Women's Health - Ongoing Clinical Trials 35
4 Women's Health - Pipeline Products under Development by Companies 36
- 4.1 Women's Health Companies - Pipeline Products by Stage of Development 36
- 4.2 Women's Health - Pipeline Products by Stage of Development 41
5 Women's Health Companies and Product Overview 47
- 5.1 AblaCare Company Overview 47
- 5.1.1 AblaCare Pipeline Products & Ongoing Clinical Trials Overview 47
- 5.2 AdneXXA LLC Company Overview 50
- 5.2.1 AdneXXA LLC Pipeline Products & Ongoing Clinical Trials Overview 50
- 5.3 Advanced Prenatal Therapeutics, Inc. Company Overview 51
- 5.3.1 Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
- 5.4 Advanced Tactile Imaging Inc Company Overview 52
- 5.4.1 Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 52
- 5.5 AEGEA Medical Inc Company Overview 55
- 5.5.1 AEGEA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 55
- 5.6 Aethlon Medical Inc Company Overview 56
- 5.6.1 Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56
- 5.7 Agile Therapeutics Inc Company Overview 57
- 5.7.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
- 5.8 Allergan Plc Company Overview 60
- 5.8.1 Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 60
- 5.9 AltaScience Limited Company Overview 62
- 5.9.1 AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview 62
- 5.10 Alydia Health Inc Company Overview 63
- 5.10.1 Alydia Health Inc Pipeline Products & Ongoing Clinical Trials Overview 63
- 5.11 Amniotix Technologies Ltd Company Overview 66
- 5.11.1 Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 66
- 5.12 ANALYTICA PTY LTD Company Overview 67
- 5.12.1 ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview 67
- 5.13 Aneeve Nanotechnologies LLC Company Overview 68
- 5.13.1 Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 68
- 5.14 Aspivix SA Company Overview 69
- 5.14.1 Aspivix SA Pipeline Products & Ongoing Clinical Trials Overview 69
- 5.15 Bayer AG Company Overview 70
- 5.15.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 70
- 5.16 Baystate Medical Center Company Overview 72
- 5.16.1 Baystate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 72
- 5.17 Becton Dickinson and Co Company Overview 73
- 5.17.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 73
- 5.18 BeFree! Company Overview 76
- 5.18.1 BeFree! Pipeline Products & Ongoing Clinical Trials Overview 76
- 5.19 BellaSeno GmbH Company Overview 77
- 5.19.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 77
- 5.20 Bewell Connect Corp Company Overview 78
- 5.20.1 Bewell Connect Corp Pipeline Products & Ongoing Clinical Trials Overview 78
6 Women's Health- Recent Developments 289
- 6.1 Nov 19, 2019: Edan to highlight its new developments at MEDICA 2019 289
- 6.2 Nov 19, 2019: Clinical Innovations hires Rebecca Liu as VP, general manager for CI Medical Instruments in China 289
- 6.3 Nov 18, 2019: A new self-use innovative treatment for pelvic organ prolapse in women (POP) designed by ConTIPI Medical 290
- 6.4 Nov 18, 2019: Barbro Friden steps down as a member of the board of Vitrolife 291
- 6.5 Nov 14, 2019: Merck acquires Calporta Therapeutics for $576m 291
- 6.6 Nov 14, 2019: INVO Bioscience reports third quarter 2019 financial results 291
- 6.7 Nov 13, 2019: BellaSeno and Evonik to launch 3D-printed absorbable breast scaffold 293
- 6.8 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories 294
- 6.9 Nov 13, 2019: Atossa Genetics announces third quarter 2019 financial results and provides company update 294
- 6.10 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance 296
7 Appendix 600
- 7.1 Methodology 600
- 7.2 About GlobalData 603
- 7.3 Contact Us 603
Summary:
Get latest Market Research Reports on Women's Health. Industry analysis & Market Report on Women's Health is a syndicated market report, published as Women's Health - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Women's Health market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
